Glaxo and Theravance Suffer Setback

GlaxoSmithKline and Theravance have announced top-line data from pivotal phase III studies of Relovair.

Inverseon Focuses on Mucous and Smoking Cessation

SAN FRANCISCO , Jan. 12, 2012 /PRNewswire/ -- Inverseon, Inc., a pharmaceutical company developing drug therapies for the treatment of pulmonary disorders, announced that while it anticipates that its ...

Glaxo and Theravance Suffer Setback - Analyst Blog

GlaxoSmithKline ( GSK ) and Theravance, Inc. ( THRX ) recently announced top-line data from pivotal phase III studies conducted with pipeline candidate, Relovair, for chronic

Reducing Inflammation Brings Pain Relief With Bonus Of Better Long Term Health Benefits

Chronic inflammation sufferers will find pain relief from anti-inflammatory products offered by all natural nutrition company, True Healthy Products.(PRWEB) January 20, 2012 True Healthy Products now offers anti-inflammatory products which will relieve pain for those who suffer chronic inflammation. Inflammation can attack any part of our bodies, this imbalance of the system is caused by many ...

GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair(TM)* in COPD and ...

LONDON and SOUTH SAN FRANCISCO, CA-- - GlaxoSmithKline and Theravance, Inc. today announced the completion of the phase III registration programme for the once-daily investigational medicine Relovair™* ...